Literature DB >> 16712710

Roles of the transcription factor p53 in keratinocyte carcinomas.

D E Brash1.   

Abstract

The transcription factor p53 is mutated in most keratinocyte carcinomas (nonmelanoma skin cancers). In these tumours, the gene bears the trace of its mutagen, sunlight. Sunlight-induced p53 mutations are also seen in skin precancers and even sun-exposed skin, which harbours thousands of p53-mutant keratinocyte clones. Normal p53 is upregulated by sunlight exposure, after which it acts as a tumour suppressor in several ways: increasing DNA repair, arresting the cell cycle and inducing apoptosis of badly damaged keratinocytes. This UV-induced upregulation has been used as an assay for assessing the effectiveness of sunscreens. Once mutated, however, p53 renders cells apoptosis-resistant and therefore less sensitive to sunlight overexposure than normal cells. This reversal of roles drives clonal expansion of precancerous keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16712710     DOI: 10.1111/j.1365-2133.2006.07230.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  28 in total

1.  Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17.

Authors:  Juan Guinea-Viniegra; Rainer Zenz; Harald Scheuch; María Jiménez; Latifa Bakiri; Peter Petzelbauer; Erwin F Wagner
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

2.  Bad things happen in the basal layer: KLF4 and squamous cell carcinoma.

Authors:  Wen Jiang; Susan M Lobo-Ruppert; J Michael Ruppert
Journal:  Cancer Biol Ther       Date:  2008-05-14       Impact factor: 4.742

3.  Fluorouracil Enhances Photodynamic Therapy of Squamous Cell Carcinoma via a p53-Independent Mechanism that Increases Protoporphyrin IX levels and Tumor Cell Death.

Authors:  Sanjay Anand; Kishore R Rollakanti; Nikoleta Brankov; Douglas E Brash; Tayyaba Hasan; Edward V Maytin
Journal:  Mol Cancer Ther       Date:  2017-03-23       Impact factor: 6.261

4.  Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma.

Authors:  Janine G Einspahr; Valerie Calvert; David S Alberts; Clara Curiel-Lewandrowski; James Warneke; Robert Krouse; Steven P Stratton; Lance Liotta; Caterina Longo; Giovanni Pellacani; Giovanni Pellicani; Anil Prasad; Paul Sagerman; Yira Bermudez; Jianghong Deng; G Timothy Bowden; Emanuel F Petricoin
Journal:  Cancer Prev Res (Phila)       Date:  2012-03

5.  Ultraviolet radiation and 12-O-tetradecanoylphorbol-13-acetate-induced interaction of mouse epidermal protein kinase Cε with Stat3 involve integration with ERK1/2.

Authors:  Jordan Marshall Sand; Bilal Bin Hafeez; Moammir Hasan Aziz; Emily Marie Siebers; Nancy Ellen Dreckschmidt; Ajit Kumar Verma
Journal:  Mol Carcinog       Date:  2011-04-07       Impact factor: 4.784

Review 6.  Peptide Hormone Regulation of DNA Damage Responses.

Authors:  Vera Chesnokova; Shlomo Melmed
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

7.  Squamous cell carcinoma of the skin: Emerging need for novel biomarkers.

Authors:  Atte Kivisaari; Veli-Matti Kähäri
Journal:  World J Clin Oncol       Date:  2013-11-10

8.  Arsenite-mediated promotion of anchorage-independent growth of HaCaT cells through placental growth factor.

Authors:  Ichiro Yajima; Mayuko Y Kumasaka; Shoko Ohnuma; Nobutaka Ohgami; Hisao Naito; Hossain U Shekhar; Yasuhiro Omata; Masashi Kato
Journal:  J Invest Dermatol       Date:  2014-12-10       Impact factor: 8.551

9.  Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing.

Authors:  Alberto Paniz-Mondolfi; Rajesh Singh; George Jour; Mandana Mahmoodi; A Hafeez Diwan; Bedia A Barkoh; Ronald Cason; Yve Huttenbach; Gustavo Benaim; John Galbincea; Rajyalakshmi Luthra
Journal:  Virchows Arch       Date:  2014-07-17       Impact factor: 4.064

10.  p21CIP1 controls the squamous differentiation response to replication stress.

Authors:  Isabel de Pedro; Jesús Galán-Vidal; Ana Freije; Ernesto de Diego; Alberto Gandarillas
Journal:  Oncogene       Date:  2020-10-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.